NCT01555476View on ClinicalTrials.gov

Study to Test the Blood to See if a New Medicine is Likely to Provide Pain Relief Similar to a Product Already Sold in Stores

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Pain
Interventions
DRUG

Ibuprofen

A single 5 mL dose of 200 mg ibuprofen/5 mL experimental suspension, administered orally, with a 48-hour washout between visits

DRUG

Ibuprofen

A single 5 mL dose of 200 mg ibuprofen/5 mL reference suspension, administered orally, with a 48-hour washout between visits

Trial Locations (1)

222 20

McNeil AB Clinical Pharmacology R&D, Lund

Sponsors

Lead Sponsor

McNeil AB
All Listed Sponsors
lead

McNeil AB

INDUSTRY